Table 1.
Hemorheological parameters of different treatment (mean ± SD) (n = 8, each)
| YXC (g/kg) | Swimming (h) | Plasma viscosity(mP.s) | Blood viscosity (mP.s)(10s −1 ) | Blood iscosity (mP.s)(200 s -1 ) | FIB (g/L) | HCT (%) | TT (s) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 1.09 ± 0.14 | 6.10 ± 0.96 | 3.41 ± 0.22 | 3.74 ± 0.78 | 45.46 ± 2.10 | 27.57 ± 1.83 | ||||||
| 0 | 0.5 | 1.00 ± 0.05 | 4.92 ± 0.77 | 3.02 ± 0.20 | 4.94 ± 1.20 | 41.23 ± 4.68 | 28.59 ± 2.24 | ||||||
| 0 | 1 | 0.99 ± 0.04 | 6.09 ± 0.73 | 3.20 ± 0.09 | 3.57 ± 0.67 | 45.44 ± 1.61 | 27.20 ± 0.99 | ||||||
| 1 | 0 | 1.03 ± 0.07 | 5.24 ± 0.97 | 3.05 ± 0.30 | 4.14 ± 1.03 | 41.35 ± 5.71 | 27.47 ± 0.85 | ||||||
| 1 | 0.5 | 1.04 ± 0.05 | 5.50 ± 0.60 | 3.12 ± 0.21 | 3.81 ± 0.60 | 42.32 ± 3.75 | 27.94 ± 1.67 | ||||||
| 1 | 1 | 1.01 ± 0.02 | 5.27 ± 0.89 | 3.05 ± 0.22 | 3.58 ± 0.20 | 41.24 ± 4.12 | 28.45 ± 1.77 | ||||||
| 2 | 0 | 0.98 ± 0.02 | 5.08 ± 0.87 | 2.95 ± 0.21 | 3.77 ± 0.29 | 40.66 ± 2.95 | 27.28 ± 1.41 | ||||||
| 2 | 0.5 | 1.00 ± 0.04 | 5.64 ± 0.67 | 3.18 ± 0.13 | 3.44 ± 0.27 | 44.03 ± 2.48 | 27.37 ± 1.09 | ||||||
| 2 | 1 | 1.01 ± 0.05 | 5.45 ± 0.84 | 3.18 ± 0.24 | 3.70 ± 0.74 | 42.55 ± 4.51 | 28.17 ± 1.01 | ||||||
| Two-way ANOVA | F | P | F | P | F | P | F | P | F | P | F | P | |
| YXC | 2.365 | 0.101 | 1.496 | 0.237 | 3.153 | 0.049 | 2.413 | 0.098 | 2.720 | 0.073 | 0.168 | 0.845 | |
| Swimming | 1.707 | 0.177 | 0.601 | 0.551 | 0.236 | 0.791 | 2.065 | 0.135 | 0.205 | 0.815 | 0.831 | 0.440 | |
| YXC × Swimming | 3.276 | 0.016 | 3.192 | 0.018 | 5.263 | 0.001 | 4.052 | 0.005 | 2.554 | 0.047 | 0.855 | 0.495 | |
All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergism effect. Comparisons between each pair of factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 was considered statistically significant.